Acadia Pharmaceuticals (ACAD) Cash from Investing Activities Growth (1y) (2011 - 2026)
Acadia Pharmaceuticals (ACAD) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Cash from Investing Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
-114.28% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
826.39% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
-674.01% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Acadia Pharmaceuticals |
3.68 Bn |
2.83 Bn |
243.27 Mn |
153.43% |
| Date | Value |
|---|
| Mar 31, 2026 |
153.43% |
| Dec 31, 2025 |
-145.74% |
| Sep 30, 2025 |
3.77% |
| Jun 30, 2025 |
22.95% |
| Mar 31, 2025 |
-783.60% |
| Dec 31, 2024 |
35,301.73% |
| Sep 30, 2024 |
-341.74% |
| Jun 30, 2024 |
71.08% |
| Mar 31, 2024 |
-107.29% |
| Dec 31, 2023 |
98.04% |
| Sep 30, 2023 |
120.91% |
| Jun 30, 2023 |
-248.20% |
| Mar 31, 2023 |
46.57% |
| Dec 31, 2022 |
-124.81% |
| Sep 30, 2022 |
109.88% |
| Jun 30, 2022 |
-224.27% |
| Mar 31, 2022 |
325.38% |
| Dec 31, 2021 |
161.17% |
| Sep 30, 2021 |
-202.17% |
| Jun 30, 2021 |
-113.56% |
